DOD Melanoma Idea Award


Funding Opportunity ID: 333426
Opportunity Number: W81XWH-21-MRP-IA
Opportunity Title: DOD Melanoma Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 12.420
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: DOD-AMRAA
Agency Name: Department of Defense
Dept. of the Army — USAMRAA
Posted Date: May 07, 2021
Close Date: Sep 28, 2021
Last Updated Date: May 07, 2021
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $8,000,000
Expected Number of Awards: 10
Description: The FY21 MRP Idea Award supports innovative, untested, exploratory, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in melanoma research. The advancement of knowledge in melanoma research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.The purpose of the Idea Award is to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed research. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project can be exploratory, hypothesis-driven or hypothesis-generating research but must be based on a strong scientific rationale and a well-developed study design and plan of analysis.The Idea Award is not intended to expand or extend previously published findings or continue an established line of research. Incremental advances, the next logical step, or switching the object or method of inquiry from one cancer to another cancer is not considered innovative.Studies involving non-melanoma skin cancers are not allowed under the FY21 MRP.
Version: 1

Visit the Official Webpage For More Details on DOD Melanoma Idea Award


Please enter your comment!
Please enter your name here